Sleep disturbance. Nonorganic sleep disorders
Conditions
Interventions
Intervention 1: Interventionl group recieve Gabapentin300 mg twice daily for 12 weeks. Intervention 2: Control group recieve placebo twice daily for 12 weeks.
Treatment - Drugs
Interventionl group recieve Gabapentin300 mg twice daily for 12 weeks
Control group recieve placebo twice daily for 12 weeks.
Sponsors
Arak University Medical of Sciences
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Inclusion criteria: passing at least 1 year after last menstural period; absence of any physical or psychiatric disease; do not using any drug and alcohale and smoking; a score of at least 5 in Pittsburg sleep quality index; informed written consent. Exclusion criteria: occuring of any physical or psychiatric disease during study which causes sleep disturbance and noncompliance.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pittsburg sleep quality index. Timepoint: before intervention and at the end of intervention. Method of measurement: clinical examination.;Quality of life questionnaire SF36. Timepoint: before intervention and the end of intervention. Method of measurement: clinical examination. | — |
Secondary
| Measure | Time frame |
|---|---|
| Somnolance and dizzines. Timepoint: Before intervention and at the end of intervention. Method of measurement: Clinical examination. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMehri jamilian
Arak University of Medical Sciences
Outcome results
None listed